Table 1.

Patients’ characteristics

Characteristics	Value
All patients	41
Age, median (range)	70 (33–92)
Male/female	11/30
Performance status, 0/1/2/3/4	13/21/7/0/0
Follow-up (months), median (range)	49 (7–138)
Total tumor volume (ml), median (range)	10.4 (1.4–56.9)
SRS
No. of patients	9
Tumor volume (ml), median (range)	4.6 (1.7–29.3)
Dose (Gy), median (range)	17 (13–20)
hSRT
No. of patients	32
Tumor volume (ml), median (range)	11.3 (1.4–56.9)
2 fractions dose (Gy)	14
3 fractions dose (Gy), median (range)	21 (14.5–24)
5 fractions dose (Gy), median (range)	25 (18–30)
10 fractions dose (Gy)	38

hSRT: hypofractionated stereotactic radiotherapy, SRS: stereotactic radiosurgery.